Moolec Science (MLEC) Other Accumulated Expenses (2022)
Moolec Science's (MLEC) quarterly Other Accumulated Expenses came in at $838117.0 in Q4 2022, up 71472.76% quarter-over-quarter from $1171.0 in Q2 2022.
Moolec Science (MLEC) Other Accumulated Expenses (2022) Analysis & Trends
Moolec Science has disclosed Other Accumulated Expenses across 1 years of filings, most recently posting $838117.0 for Q4 2022.
- Other Accumulated Expenses for Q4 2022 came in at $838117.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $838117.0 (changed N/A YoY), and the FY2022 annual result was $1171.0, changed N/A from the prior year.
- Other Accumulated Expenses came in at $838117.0 for Q4 2022 at Moolec Science, up from $1171.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $838117.0 in Q4 2022 to a low of $1171.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 838,117.00 |
| Jun 30, 2022 | 1,171.00 |